Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gamida Cell
Biotech
Marea, Ashibio, Arvinas & more—Chutes & Ladders
Cardiometabolic biotech Marea unveils C-suite. Ashibio exits stealth with newly appointed leaders. Arvinas CSO steps into new role after 5 years
Gabrielle Masson
,
Andrea Park
,
Fraiser Kansteiner
Jun 21, 2024 8:30am
Gamida accepts sale to investment firm to survive
Mar 27, 2024 9:53am
Cash-strapped Gamida steps up search for strategic alternatives
Jan 29, 2024 8:41am
Gamida lays off 17%, ditches NKs to keep omidubicel going
Mar 27, 2023 9:30am
FDA extends review of Gamida Cell's approval by 3 months
Nov 22, 2022 10:55am
Gamida drops mixed bag of news on FDA submission, staffing cuts
Jan 31, 2022 9:31am